
Sean E. Aeder
Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1939 |
| Issued Applications | 907 |
| Pending Applications | 201 |
| Abandoned Applications | 855 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8707546
[patent_doc_number] => 20130064835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'RAGE REGULATES ROCK ACTIVITY IN CARDIOVASCULAR DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/500885
[patent_app_country] => US
[patent_app_date] => 2010-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 28012
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500885
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/500885 | RAGE REGULATES ROCK ACTIVITY IN CARDIOVASCULAR DISEASE | Oct 7, 2010 | Abandoned |
Array
(
[id] => 6188731
[patent_doc_number] => 20110171641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-14
[patent_title] => 'Gene Expression Markers of Recurrence Risk in Cancer Patients After Chemotherapy'
[patent_app_type] => utility
[patent_app_number] => 12/900388
[patent_app_country] => US
[patent_app_date] => 2010-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 28396
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20110171641.pdf
[firstpage_image] =>[orig_patent_app_number] => 12900388
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/900388 | Gene Expression Markers of Recurrence Risk in Cancer Patients After Chemotherapy | Oct 6, 2010 | Abandoned |
Array
(
[id] => 8660065
[patent_doc_number] => 20130040894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'INHIBITION OR ACTIVATION OF SERINE/THREONINE ULK3 KINASE ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 13/500902
[patent_app_country] => US
[patent_app_date] => 2010-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10145
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500902
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/500902 | INHIBITION OR ACTIVATION OF SERINE/THREONINE ULK3 KINASE ACTIVITY | Oct 5, 2010 | Abandoned |
Array
(
[id] => 8289791
[patent_doc_number] => 20120178111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE DETECTION OF LUNG CANCERS'
[patent_app_type] => utility
[patent_app_number] => 13/497629
[patent_app_country] => US
[patent_app_date] => 2010-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 46040
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497629
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/497629 | METHODS AND COMPOSITIONS FOR THE DETECTION OF LUNG CANCERS | Sep 22, 2010 | Abandoned |
Array
(
[id] => 5976005
[patent_doc_number] => 20110070268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-24
[patent_title] => 'Method'
[patent_app_type] => utility
[patent_app_number] => 12/884407
[patent_app_country] => US
[patent_app_date] => 2010-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 44242
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20110070268.pdf
[firstpage_image] =>[orig_patent_app_number] => 12884407
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/884407 | Method | Sep 16, 2010 | Abandoned |
Array
(
[id] => 6055071
[patent_doc_number] => 20110111431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'METHOD FOR IDENTIFYING PRE-NEOPLASTIC AND/OR NEOPLASTIC STATES IN MAMMALS'
[patent_app_type] => utility
[patent_app_number] => 12/878865
[patent_app_country] => US
[patent_app_date] => 2010-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7247
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20110111431.pdf
[firstpage_image] =>[orig_patent_app_number] => 12878865
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/878865 | METHOD FOR IDENTIFYING PRE-NEOPLASTIC AND/OR NEOPLASTIC STATES IN MAMMALS | Sep 8, 2010 | Abandoned |
Array
(
[id] => 5992549
[patent_doc_number] => 20110014202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'Methods for Diagnosing and Treating Neuroendocrine Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/876312
[patent_app_country] => US
[patent_app_date] => 2010-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13284
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20110014202.pdf
[firstpage_image] =>[orig_patent_app_number] => 12876312
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/876312 | Methods for diagnosing and treating neuroendocrine cancer | Sep 6, 2010 | Issued |
Array
(
[id] => 8227805
[patent_doc_number] => 20120142012
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'BIOMARKER FOR COLORECTAL CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/390532
[patent_app_country] => US
[patent_app_date] => 2010-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9549
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390532
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/390532 | Biomarker for colorectal cancer | Sep 5, 2010 | Issued |
Array
(
[id] => 8351849
[patent_doc_number] => 08247183
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-21
[patent_title] => 'Compositions and methods for diagnosis and treatment of tumors'
[patent_app_type] => utility
[patent_app_number] => 12/871669
[patent_app_country] => US
[patent_app_date] => 2010-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 35088
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12871669
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/871669 | Compositions and methods for diagnosis and treatment of tumors | Aug 29, 2010 | Issued |
Array
(
[id] => 7779811
[patent_doc_number] => 20120041686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'DIAGNOSTIC FOR LUNG DISORDERS USING CLASS PREDICTION'
[patent_app_type] => utility
[patent_app_number] => 12/869525
[patent_app_country] => US
[patent_app_date] => 2010-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 32192
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20120041686.pdf
[firstpage_image] =>[orig_patent_app_number] => 12869525
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/869525 | DIAGNOSTIC FOR LUNG DISORDERS USING CLASS PREDICTION | Aug 25, 2010 | Abandoned |
Array
(
[id] => 6201961
[patent_doc_number] => 20110064747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'METHODS FOR TREATMENT OF A SARCOMA USING AN EPIMETABOLIC SHIFTER (COENZYME Q10)'
[patent_app_type] => utility
[patent_app_number] => 12/868678
[patent_app_country] => US
[patent_app_date] => 2010-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 63735
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20110064747.pdf
[firstpage_image] =>[orig_patent_app_number] => 12868678
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/868678 | METHODS FOR TREATMENT OF A SARCOMA USING AN EPIMETABOLIC SHIFTER (COENZYME Q10) | Aug 24, 2010 | Abandoned |
Array
(
[id] => 5928903
[patent_doc_number] => 20110038862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'METHOD AND KIT FOR THE DETECTION OF GENES ASSOCIATED WITH PIK3CA MUTATION AND INVOLVED IN PI3K/AKT PATHWAY ACTIVATION IN THE ER-POSTITIVE AND HER2-POSITIVE SUBTYPES WITH CLINICAL IMPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/860638
[patent_app_country] => US
[patent_app_date] => 2010-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 14100
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20110038862.pdf
[firstpage_image] =>[orig_patent_app_number] => 12860638
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/860638 | Method and kit for the detection of genes associated with PIK3CA mutation and involved in PI3K/AKT pathway activation in the ER-postitive and HER2-positive subtypes with clinical implications | Aug 19, 2010 | Issued |
Array
(
[id] => 5935937
[patent_doc_number] => 20110212085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-01
[patent_title] => 'LUNG CANCER DISEASE TARGETS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/859440
[patent_app_country] => US
[patent_app_date] => 2010-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44786
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20110212085.pdf
[firstpage_image] =>[orig_patent_app_number] => 12859440
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/859440 | LUNG CANCER DISEASE TARGETS AND USES THEREOF | Aug 18, 2010 | Abandoned |
Array
(
[id] => 9009160
[patent_doc_number] => 08524456
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-03
[patent_title] => 'Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers'
[patent_app_type] => utility
[patent_app_number] => 12/859526
[patent_app_country] => US
[patent_app_date] => 2010-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 28082
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12859526
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/859526 | Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers | Aug 18, 2010 | Issued |
Array
(
[id] => 8927913
[patent_doc_number] => 20130183673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-18
[patent_title] => 'NEW MARKERS FOR THE EPITHELIAL AND PROLIFERATIVE OR MESENCHYMAL INVASIVE PHENOTYPE OF HUMAN NEOPLASIAS'
[patent_app_type] => utility
[patent_app_number] => 13/816339
[patent_app_country] => US
[patent_app_date] => 2010-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15530
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816339
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/816339 | NEW MARKERS FOR THE EPITHELIAL AND PROLIFERATIVE OR MESENCHYMAL INVASIVE PHENOTYPE OF HUMAN NEOPLASIAS | Aug 10, 2010 | Abandoned |
Array
(
[id] => 6264901
[patent_doc_number] => 20100297658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'DETECTING METHYLATED MAMMALIAN NUCLEIC ACID IN STOOL'
[patent_app_type] => utility
[patent_app_number] => 12/851872
[patent_app_country] => US
[patent_app_date] => 2010-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4819
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20100297658.pdf
[firstpage_image] =>[orig_patent_app_number] => 12851872
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/851872 | DETECTING METHYLATED MAMMALIAN NUCLEIC ACID IN STOOL | Aug 5, 2010 | Abandoned |
Array
(
[id] => 6202350
[patent_doc_number] => 20110065136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'Methods and Devices for Detecting Glomerulonephritis and Associated Disorders'
[patent_app_type] => utility
[patent_app_number] => 12/852152
[patent_app_country] => US
[patent_app_date] => 2010-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 17287
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065136.pdf
[firstpage_image] =>[orig_patent_app_number] => 12852152
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/852152 | Methods and Devices for Detecting Glomerulonephritis and Associated Disorders | Aug 5, 2010 | Abandoned |
Array
(
[id] => 5943565
[patent_doc_number] => 20110104185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'ANTIBODY FRAGMENT-POLYMER CONJUGATES AND USES OF SAME'
[patent_app_type] => utility
[patent_app_number] => 12/850490
[patent_app_country] => US
[patent_app_date] => 2010-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 144
[patent_figures_cnt] => 144
[patent_no_of_words] => 111610
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20110104185.pdf
[firstpage_image] =>[orig_patent_app_number] => 12850490
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/850490 | Antibody fragment-polymer conjugates and uses of same | Aug 3, 2010 | Issued |
Array
(
[id] => 6165739
[patent_doc_number] => 20110195478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-11
[patent_title] => 'BLADDER CANCER BIOMARKER AND TEST METHOD USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/849988
[patent_app_country] => US
[patent_app_date] => 2010-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5372
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20110195478.pdf
[firstpage_image] =>[orig_patent_app_number] => 12849988
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/849988 | BLADDER CANCER BIOMARKER AND TEST METHOD USING THE SAME | Aug 3, 2010 | Abandoned |
Array
(
[id] => 8429704
[patent_doc_number] => 20120251579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'COMPOSITIONS FOR GENERATING AN ANTIGEN SPECIFIC IMMUNE RESPONSE'
[patent_app_type] => utility
[patent_app_number] => 13/386590
[patent_app_country] => US
[patent_app_date] => 2010-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 10507
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13386590
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/386590 | COMPOSITIONS FOR GENERATING AN ANTIGEN SPECIFIC IMMUNE RESPONSE | Jul 29, 2010 | Abandoned |